Zhongchao Inc. Collaborates With A Public Health Foundation To Support Sustainable And Effective Cancer Treatments
Portfolio Pulse from Benzinga Newsdesk
Zhongchao Inc. (ZCMD) renews its service agreement with Beijing Public Health Foundation to provide free medication assistance services for cancer patients through its subsidiary Zhongxin. The Project, in operation for three years, has served over 6,000 patients and donated over 22,000 doses of medication. It operates through 300 hospitals and 100 pharmacies, offering free Doxorubicin Hydrochloride Liposome Injections to low-income patients with various cancers. Zhongxin is responsible for staff training, daily operations, and project management, aiming to improve treatment efficiency and reduce financial burden on patients.
December 11, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zhongchao Inc. extends its collaboration with BPHF to provide essential cancer treatments at no cost, demonstrating its commitment to corporate responsibility and patient care.
The renewal of the service agreement with BPHF is likely to be viewed positively by investors and could enhance Zhongchao's reputation for corporate responsibility. This initiative may lead to increased investor confidence and a potential short-term positive impact on ZCMD's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100